The page you were trying to view does not exists or may have expired. Below are the list of similar positions in our database.
Similar Posts
-
, 1537-1548.e29 (2018). doi: 10.1016/j.cell.2018.07.022 3. Janecki, D., Sen, R., Szóstak, N., Kajdasz, A., Kordyś, M., Plawgo, K., Pandakov, D., Philips, A., Warkocki, Z. LINE-1 mRNA 3’ end
-
Biobank (WCB) and has strong links with the Division of Infection and immunity (DII) , the Centre for Trials Research (CTR) , the Medicines Discovery Institute (MDI) , and the European Cancer Stem Cell
-
-1548.e29 (2018). doi: 10.1016/j.cell.2018.07.022 3. Janecki, D., Sen, R., Szóstak, N., Kajdasz, A., Kordyś, M., Plawgo, K., Pandakov, D., Philips, A., Warkocki, Z. LINE-1 mRNA 3’ end dynamics
-
Research Scientist Dana-Farber Cancer Institute Boston, MA Full Time The Center for Patient Derived Models (CPDM) at DFCI is seeking applicants for the position of Research Scientist I. This is an
-
potential treatment to perturb tumourigenesis and metastasis. The candidate will receive training in CRISPR-mediated genetic editing, molecular analysis of cancer cells, 3-Dimensional culture techniques
-
primate models. Research Scientists are individuals holding a Ph. D or equivalent terminal degree who play a major role in enabling research programs through collaborative and collegial interactions with
-
the aim of developing innovative strategies to improve human health. HT has the mission of conducting cutting-edge research and translate innovation into methods available to the entire National scientific
-
development in animal models Techniques used: State of the art imaging techniques including 3-dimensional electron microscopy, confocal microscopy and atomic force microscopy. Molecular cell biology, animal